Intravenous immunoglobulin therapy for Miller Fisher syndrome
Abstract
We analyzed clinical recovery of 92 patients with Miller Fisher syndrome who had been treated with IV immunoglobulin (IVIg; n = 28), plasmapheresis (n = 23), and no immune treatment (n = 41). IVIg slightly hastened the amelioration of ophthalmoplegia and ataxia, but the times of the disappearances of those symptoms were similar among three groups. In Miller Fisher syndrome, IVIg and plasmapheresis seem not to have influenced patients' outcomes, presumably because of good natural recovery.
Get full access to this article
View all available purchase options and get full access to this article.
Supplementary Material
References
1.
The Guillain-Barré Syndrome Study Group. Plasmapheresis and acute Guillain-Barré syndrome. Neurology 1985;35:1096–1104.
2.
van der Meché FGA, Schmitz PIM, the Dutch Guillain-Barré Study Group. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. N Engl J Med 1992;326:1123–1129.
3.
Littlewood R, Bajada S. Successful plasmapheresis in the Miller-Fisher syndrome. BMJ 1981;282:778.
4.
Arakawa Y, Yoshimura M, Kobayashi S, et al. The use of intravenous immunoglobulin in Miller Fisher syndrome. Brain Dev 1993;15:231–233.
5.
Zifko U, Drlicek M, Senautka G, Grisold W. High dose immunoglobulin therapy is effective in the Miller Fisher syndrome. J Neurol 1994;241:178–179.
6.
Fisher CM. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N Engl J Med 1956;255:57–65.
7.
Mori M, Kuwabara S, Fukutake T, Yuki N, Hattori T. Clinical features and prognosis of Miller Fisher syndrome. Neurology 2001;56:1104–1106.
8.
Mori M, Kuwabara S, Fukutake T, Hattori T. Plasmapheresis and Miller Fisher syndrome: analysis of 50 consecutive cases. J Neurol Neurosurg Psychiatry 2002;72:680.
9.
Yuki N. Tryptophan-immobilized column adsorbs immunoglobulin G anti-GQ1b antibody from Fisher's syndrome: a new approach to treatment. Neurology 1996;46:1644–1651.
10.
Jacobs BS, O'Hanlon GM, Bullens RW, Veitch J, Plomp JJ, Willison HJ. Immunoglobulins inhibit pathophysiological effects of anti-GQ1b-positive sera at motor nerve terminals through inhibition of antibody binding. Brain 2003;126:2220–2234.
Information & Authors
Information
Published In
Copyright
© 2007.
Publication History
Published online: April 2, 2007
Published in print: April 3, 2007
Authors
Metrics & Citations
Metrics
Citation information is sourced from Crossref Cited-by service.
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Cited By
- Miller Fisher syndrome without ataxia with pupil involvement, Turkish Journal of Neurology, 30, 2, (117-119), (2024).https://doi.org/10.4274/tnd.2023.32458
- 72-Year-Old Woman With Double Vision, Dysarthria, and Ptosis, Mayo Clinic Proceedings, 99, 7, (1162-1166), (2024).https://doi.org/10.1016/j.mayocp.2023.08.030
- The spectrum of anti-GQ1B antibody syndrome: beyond Miller Fisher syndrome and Bickerstaff brainstem encephalitis, Neurological Sciences, 45, 12, (5657-5669), (2024).https://doi.org/10.1007/s10072-024-07686-3
- Postinfectious Immune-Mediated Neurological Diseases, Neuroimmune Diseases, (553-566), (2024).https://doi.org/10.1007/978-3-031-60006-7_13
- Expanding Clinical Spectrum of Anti-GQ1b Antibody Syndrome, JAMA Neurology, 81, 7, (762), (2024).https://doi.org/10.1001/jamaneurol.2024.1123
- Miller Fisher Syndrome Associated With COVID-19: A History of Molecular Mimicry and an Up-to-Date Review of the Literature, Cureus, (2023).https://doi.org/10.7759/cureus.43111
- Immune-Mediated Neuropathies: Pathophysiology and Management, International Journal of Molecular Sciences, 24, 8, (7288), (2023).https://doi.org/10.3390/ijms24087288
- Miller Fisher syndrome: an updated narrative review, Frontiers in Neurology, 14, (2023).https://doi.org/10.3389/fneur.2023.1250774
- A Case with Anti-ganglioside Antibodies Showing Multiple Cranial Nerve Palsies Detected on Gadolinium-enhanced Magnetic Resonance Imaging, Internal Medicine, 62, 23, (3541-3544), (2023).https://doi.org/10.2169/internalmedicine.1389-22
- Emerging biomarkers to predict clinical outcomes in Guillain–Barré syndrome, Expert Review of Neurotherapeutics, 23, 12, (1201-1215), (2023).https://doi.org/10.1080/14737175.2023.2273386
- See more
Loading...
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.
If you need immediate support or to place an order, please call or email customer service:
- 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
- 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
- [email protected]
We appreciate your patience during this time and apologize for any inconvenience.